A case of psoriasis worsened by atorvastatin

Journal of Dermatological Case Reports

Volumn 4, Issue 3, 2009, Pages 60-61

  Cozzani, Emanuele ^a   Scaparro, Manuela ^a   Parodi, Aurora ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Adverse events; Atorvastatin; Drug eruptions; Psoriasis; Statins

Indexed keywords

ATORVASTATIN; ROSUVASTATIN;

ADULT; ARTICLE; CASE REPORT; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PSORIASIS AREA AND SEVERITY INDEX; PSORIASIS VULGARIS;

EID: 84905510725     PISSN: None     EISSN: 18987249     Source Type: Journal    
DOI: 10.3315/jdcr.2009.1037     Document Type: Article

References (6)

1. Abel EA, DiCicco LM, Orenberg EK, Fraki JE, Farber EM. Drugs in exacerbation of psoriasis Drugs in exacerbation of psoriasis. J Am Acad Dermatol. 1986;15:1007–1022.
2. Schmutz JL, Barbaud A, Tréchot P. Effets secondaires cutanés des statines. Ann Dermatol Venereol.2008;135:253–254.
3. Noël B. Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review. J Eur Acad Dermatol Venereol. 2007;21:17–24.
4. Gressier L, Pruvost-Balland C, Dubertret L, Viguier M. Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS). Ann Dermatol Venereol. 2009;136:50–53.
5. Yamamoto M, Ikeda M, Kodama H, Sano S. Transition of psoriasiform drug eruption to psoriasis de novo evidenced by histopathology. J Dermatol. 2008;35:732–736.
6. Montanaro S, Lhiaubet-Vallet V, Iesce MI, Previtera L, Miranda MA. A mechanistic study on the phototoxicity of atorvastatin: singlet oxygen generation by a phenanthrene-like photoproduct. Chem Res Toxicol. 2009;22:173–178.